Stay updated on FRα Clinical Trial: Mirvetuximab vs. Chemo
Sign up to get notified when there's something new on the FRα Clinical Trial: Mirvetuximab vs. Chemo page.

Latest updates to the FRα Clinical Trial: Mirvetuximab vs. Chemo page
- Check2 days agoChange DetectedThe page’s displayed revision/version number has been updated from v3.5.2 to v3.5.3, reflecting a release/version increment rather than substantive study information.SummaryDifference0.0%

- Check9 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2. No visible study content changes are indicated.SummaryDifference0.0%

- Check17 days agoNo Change Detected
- Check38 days agoChange DetectedWebsite revision updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check45 days agoChange DetectedFooter revision updated from v3.4.2 to v3.4.3. The page content remains the same.SummaryDifference0.0%

- Check74 days agoChange DetectedAdded Fallopian tube cancer and Primary Peritoneal carcinoma to the study conditions, expanding the list of eligible diseases. The page revision is updated to v3.4.2 and the older funding notice has been removed.SummaryDifference0.2%

- Check81 days agoChange DetectedThe page now displays a government funding status notice and updates the revision to v3.4.1, replacing v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

Stay in the know with updates to FRα Clinical Trial: Mirvetuximab vs. Chemo
Enter your email address, and we'll notify you when there's something new on the FRα Clinical Trial: Mirvetuximab vs. Chemo page.